rs3772138

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002295.6(RPSA):​c.134-32C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.303 in 1,154,172 control chromosomes in the GnomAD database, including 54,581 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). There are indicators that this mutation may affect the branch point..

Frequency

Genomes: 𝑓 0.27 ( 6025 hom., cov: 32)
Exomes 𝑓: 0.31 ( 48556 hom. )

Consequence

RPSA
NM_002295.6 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.86

Publications

17 publications found
Variant links:
Genes affected
RPSA (HGNC:6502): (ribosomal protein SA) Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Many of the effects of laminin are mediated through interactions with cell surface receptors. These receptors include members of the integrin family, as well as non-integrin laminin-binding proteins. This gene encodes a high-affinity, non-integrin family, laminin receptor 1. This receptor has been variously called 67 kD laminin receptor, 37 kD laminin receptor precursor (37LRP) and p40 ribosome-associated protein. The amino acid sequence of laminin receptor 1 is highly conserved through evolution, suggesting a key biological function. It has been observed that the level of the laminin receptor transcript is higher in colon carcinoma tissue and lung cancer cell line than their normal counterparts. Also, there is a correlation between the upregulation of this polypeptide in cancer cells and their invasive and metastatic phenotype. Multiple copies of this gene exist, however, most of them are pseudogenes thought to have arisen from retropositional events. Two alternatively spliced transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008]
SNORA6 (HGNC:32591): (small nucleolar RNA, H/ACA box 6)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
This position, referring to a specific DNA site, is a probable branch point but is likely benign (scored 0 / 10, using the threshold of <=3). The score ranges from 0 to 10, with values ≤3 considered benign and >5 classified as pathogenic. Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 3-39408574-C-T is Benign according to our data. Variant chr3-39408574-C-T is described in ClinVar as Benign. ClinVar VariationId is 1327975.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.316 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RPSANM_002295.6 linkc.134-32C>T intron_variant Intron 2 of 6 ENST00000301821.11 NP_002286.2 P08865A0A024R2L6
RPSANM_001304288.2 linkc.134-32C>T intron_variant Intron 2 of 6 NP_001291217.1 P08865A0A0C4DG17
SNORA6NR_002325.1 linkn.*35C>T downstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RPSAENST00000301821.11 linkc.134-32C>T intron_variant Intron 2 of 6 1 NM_002295.6 ENSP00000346067.4 P08865

Frequencies

GnomAD3 genomes
AF:
0.268
AC:
40687
AN:
151940
Hom.:
6014
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.160
Gnomad AMI
AF:
0.217
Gnomad AMR
AF:
0.287
Gnomad ASJ
AF:
0.355
Gnomad EAS
AF:
0.274
Gnomad SAS
AF:
0.280
Gnomad FIN
AF:
0.296
Gnomad MID
AF:
0.234
Gnomad NFE
AF:
0.320
Gnomad OTH
AF:
0.261
GnomAD2 exomes
AF:
0.294
AC:
73881
AN:
251424
AF XY:
0.296
show subpopulations
Gnomad AFR exome
AF:
0.157
Gnomad AMR exome
AF:
0.288
Gnomad ASJ exome
AF:
0.363
Gnomad EAS exome
AF:
0.251
Gnomad FIN exome
AF:
0.300
Gnomad NFE exome
AF:
0.321
Gnomad OTH exome
AF:
0.302
GnomAD4 exome
AF:
0.309
AC:
309251
AN:
1002114
Hom.:
48556
Cov.:
14
AF XY:
0.308
AC XY:
159766
AN XY:
519416
show subpopulations
African (AFR)
AF:
0.157
AC:
3865
AN:
24576
American (AMR)
AF:
0.287
AC:
12680
AN:
44126
Ashkenazi Jewish (ASJ)
AF:
0.362
AC:
8433
AN:
23302
East Asian (EAS)
AF:
0.291
AC:
10939
AN:
37582
South Asian (SAS)
AF:
0.274
AC:
21105
AN:
77114
European-Finnish (FIN)
AF:
0.298
AC:
15851
AN:
53238
Middle Eastern (MID)
AF:
0.237
AC:
1158
AN:
4892
European-Non Finnish (NFE)
AF:
0.320
AC:
221462
AN:
691976
Other (OTH)
AF:
0.304
AC:
13758
AN:
45308
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
11908
23815
35723
47630
59538
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5548
11096
16644
22192
27740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.268
AC:
40711
AN:
152058
Hom.:
6025
Cov.:
32
AF XY:
0.267
AC XY:
19880
AN XY:
74320
show subpopulations
African (AFR)
AF:
0.160
AC:
6660
AN:
41498
American (AMR)
AF:
0.287
AC:
4385
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.355
AC:
1231
AN:
3466
East Asian (EAS)
AF:
0.274
AC:
1419
AN:
5174
South Asian (SAS)
AF:
0.282
AC:
1361
AN:
4830
European-Finnish (FIN)
AF:
0.296
AC:
3114
AN:
10536
Middle Eastern (MID)
AF:
0.207
AC:
61
AN:
294
European-Non Finnish (NFE)
AF:
0.320
AC:
21733
AN:
67974
Other (OTH)
AF:
0.260
AC:
549
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1493
2987
4480
5974
7467
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
414
828
1242
1656
2070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.300
Hom.:
2599
Bravo
AF:
0.260
Asia WGS
AF:
0.259
AC:
903
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Familial isolated congenital asplenia Benign:1
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
3.8
DANN
Benign
0.70
PhyloP100
-1.9
BranchPoint Hunter
0.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3772138; hg19: chr3-39450065; COSMIC: COSV57191610; COSMIC: COSV57191610; API